Literature DB >> 19693466

Expression and significance of TGF-beta1/Smad signaling pathway in children with IgA nephropathy.

Wei Wu1, Xiao-Yun Jiang, Qiao-Ling Zhang, Ying Mo, Liang-Zhong Sun, Shu-Mei Chen.   

Abstract

BACKGROUND: IgA nephropathy (IgAN) exhibits an indolent but slowly progressive course, and about 30% of children with IgAN are found to deteriorate to end-stage renal failure characterized by overaccumulation of extracellular matrix, diffuse glomerular sclerosis, and tubulointerstitial fibrosis. The TGF-beta/Smad signaling pathway plays an important role in glomerulosclerosis and tubulointerstitial fibrosis. The present study aimed to elucidate the significance of expressions of TGF-beta1, phosphorylated Smad3 (p-Smad3), Smad7 and fibronectin (FN) in the renal tissue of children with IgAN.
METHODS: Forty-six children with IgAN were divided into 3 groups according to their clinical features: isolated hematuria group (IH group, 8 patients), hematuria and proteinuria group (HP group, 24), and nephritic syndrome group (NS group, 14). Patients were also divided into three groups according to their pathologic grade: grade I+II (22 patients), grade III (12) and grade IV (12) groups. Five normal renal specimens were used as the control group. The expression of TGF-beta1, p-Smad3, Smad7 and FN in renal biopsy specimens was detected by two-step PowerVision. The degrees of renal tubular injury and interstitial fibrosis were scored according to the Katafuchi semi-quantitative criteria.
RESULTS: The expression of TGF-beta1, p-Smad3, Smad7 and FN in children with IgAN was significantly higher than that in the control group (in glomeruli: P<0.05, P<0.01, P<0.05 and P<0.01, respectively; in tubulointerstitium: P<0.05, P<0.05, P<0.01 and P<0.05, respectively) and the highest expression levels were found in the NS and grade IV groups (P<0.05, P<0.01). The expression levels of the four proteins were not only positvely correlated with each other, but also with the grade of renal tubular injury and renal interstitial fibrosis (P<0.05).
CONCLUSION: The TGF-beta1/Smad signaling pathway plays an important role in the progress of glomerular sclerosis, renal tubular injury and interstitial fibrosis in children with IgAN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19693466      PMCID: PMC5076469          DOI: 10.1007/s12519-009-0040-3

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  10 in total

Review 1.  It's a Smad world: regulation of TGF-beta signaling in the kidney.

Authors:  H William Schnaper; Tomoko Hayashida; Anne-Christine Poncelet
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

2.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  [The expressions of TGF-beta1 and Smad 2 mRNA on diseased glomeruli and their significance in the development of glomerulosclerosis].

Authors:  Yonghua Ruan; Zhigang Zhang; Xiurong Zhang; Chen Liu; Muyi Guo
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2002-08

4.  Blockade of the effects of TGF-beta1 on mesangial cells by overexpression of Smad7.

Authors:  Ruihua Chen; Cancan Huang; Thomas A Morinelli; Maria Trojanowska; Richard V Paul
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

5.  Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney.

Authors:  Miriam C Banas; W Tony Parks; Kelly L Hudkins; Bernhard Banas; Matthew Holdren; Masayuki Iyoda; Tomasz A Wietecha; Jolanta Kowalewska; Gang Liu; Charles E Alpers
Journal:  J Histochem Cytochem       Date:  2006-12-01       Impact factor: 2.479

6.  Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation.

Authors:  R Katafuchi; Y Kiyoshi; Y Oh; N Uesugi; K Ikeda; T Yanase; S Fujimi
Journal:  Clin Nephrol       Date:  1998-01       Impact factor: 0.975

7.  Expression of transforming growth factor-beta isoforms in human glomerular diseases.

Authors:  T Yamamoto; N A Noble; A H Cohen; C C Nast; A Hishida; L I Gold; W A Border
Journal:  Kidney Int       Date:  1996-02       Impact factor: 10.612

Review 8.  Pediatric IgA nephropathy: clinical and therapeutic perspectives.

Authors:  Rosanna Coppo
Journal:  Semin Nephrol       Date:  2008-01       Impact factor: 5.299

9.  Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.

Authors:  Baoliang Guo; Daisuke Koya; Motohide Isono; Toshiro Sugimoto; Atsunori Kashiwagi; Masakazu Haneda
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

10.  Improved renal survival in Japanese children with IgA nephropathy.

Authors:  Nahoko Yata; Koichi Nakanishi; Yuko Shima; Hiroko Togawa; Mina Obana; Mayumi Sako; Kandai Nozu; Ryojiro Tanaka; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

  10 in total
  3 in total

1.  Clinicopathological and immunohistological features in childhood IgA nephropathy: a single-centre experience.

Authors:  Rezan Topaloglu; Dicle Orhan; Yelda Bilginer; Erdem Karabulut; Fatih Ozaltin; Ali Duzova; Gulsev Kale; Nesrin Besbas
Journal:  Clin Kidney J       Date:  2013-02-24

2.  Weighted Gene Co-expression Network Analysis Reveals Different Immunity but Shared Renal Pathology Between IgA Nephropathy and Lupus Nephritis.

Authors:  Ni-Ya Jia; Xing-Zi Liu; Zhao Zhang; Hong Zhang
Journal:  Front Genet       Date:  2021-03-29       Impact factor: 4.599

3.  Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway.

Authors:  Shuwen Pei; Yan Li
Journal:  Clinics (Sao Paulo)       Date:  2021-12-10       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.